ŞENGEL TÜRK, C. T. Et Al. 2020. Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.157 , 211-220.

ŞENGEL TÜRK, C. T., ALÇIĞIR, M. E., EKİM, O., BAKAR ATEŞ, F., & HASÇİÇEK, C., (2020). Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.157, 211-220.

ŞENGEL TÜRK, CEYDA Et Al. "Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model," EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.157, 211-220, 2020

ŞENGEL TÜRK, CEYDA T. Et Al. "Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model." EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.157, pp.211-220, 2020

ŞENGEL TÜRK, C. T. Et Al. (2020) . "Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model." EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.157, pp.211-220.

@article{article, author={CEYDA TUBA ŞENGEL TÜRK Et Al. }, title={Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model}, journal={EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS}, year=2020, pages={211-220} }